Marshall Wace Portfolio holdings
AUM
$84.1B
1-Year Return
27.54%
This Quarter Return
+10.81%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$60.4B
AUM Growth
+$8.03B
(+15%)
Cap. Flow
+$2.59B
Cap. Flow
% of AUM
4.29%
Top 10 Holdings %
Top 10 Hldgs %
29.58%
Holding
2,708
New
760
Increased
647
Reduced
624
Closed
461
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$433M |
| 2 |
Goldman Sachs
GS
|
+$402M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$366M |
| 4 |
Procter & Gamble
PG
|
+$331M |
| 5 |
Coca-Cola
KO
|
+$299M |
Top Sells
| 1 |
Walmart
WMT
|
+$420M |
| 2 |
Constellation Brands
STZ
|
+$371M |
| 3 |
Meta Platforms (Facebook)
META
|
+$312M |
| 4 |
Kenvue
KVUE
|
+$293M |
| 5 |
JPMorgan Chase
JPM
|
+$281M |
Sector Composition
| 1 | Technology | 17.87% |
| 2 | Healthcare | 14.24% |
| 3 | Consumer Discretionary | 13.82% |
| 4 | Financials | 8.32% |
| 5 | Communication Services | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUGX
1301
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $1.38M | ﹤0.01% |
338,445
+294,720
| +674% | +$1.21M |
|
1302
Viridian Therapeutics
VRDN
$1.54B
| $1.38M | ﹤0.01% |
78,701
-222,588
| -74% | -$3.9M |
|
1303
Heron Therapeutics
HRTX
$193M
| $1.37M | ﹤0.01% |
+494,354
| New | +$1.37M |
|
1304
Nektar Therapeutics
NKTR
$926M
| $1.37M | ﹤0.01% |
98,082
-61,001
| -38% | -$851K |
|
1305
Nelnet
NNI
$4.46B
| $1.36M | ﹤0.01% |
14,400
-2,771
| -16% | -$262K |
|
1306
Marcus Corp
MCS
$504M
| $1.36M | ﹤0.01% |
95,464
-77,932
| -45% | -$1.11M |
|
1307
ALX Oncology
ALXO
$56.8M
| $1.36M | ﹤0.01% |
121,546
+109,977
| +951% | +$1.23M |
|
1308
iShares MSCI Turkey ETF
TUR
$160M
| $1.35M | ﹤0.01% |
+37,564
| New | +$1.35M |
|
|
EGRX
1309
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.35M | ﹤0.01% |
257,469
+113,643
| +79% | +$595K |
|
1310
Pharvaris
PHVS
$1.49B
| $1.34M | ﹤0.01% |
58,169
-1,955
| -3% | -$45.2K |
|
1311
Golden Entertainment
GDEN
$638M
| $1.33M | ﹤0.01% |
+36,124
| New | +$1.33M |
|
1312
Boston Omaha
BOC
$425M
| $1.32M | ﹤0.01% |
85,445
-44,718
| -34% | -$691K |
|
1313
Xometry
XMTR
$2.59B
| $1.32M | ﹤0.01% |
78,016
+50,036
| +179% | +$845K |
|
1314
CoStar Group
CSGP
$36.8B
| $1.31M | ﹤0.01% |
13,612
-144,507
| -91% | -$14M |
|
1315
iShares MSCI USA Momentum Factor ETF
MTUM
$18.8B
| $1.31M | ﹤0.01% |
7,000
-8,644
| -55% | -$1.62M |
|
1316
Targa Resources
TRGP
$35.8B
| $1.31M | ﹤0.01% |
+11,708
| New | +$1.31M |
|
1317
Gerdau
GGB
$6.03B
| $1.31M | ﹤0.01% |
+355,487
| New | +$1.31M |
|
1318
SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$10.7B
| $1.31M | ﹤0.01% |
+40,000
| New | +$1.31M |
|
1319
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$2.99B
| $1.31M | ﹤0.01% |
+19,284
| New | +$1.31M |
|
1320
Weis Markets
WMK
$1.75B
| $1.31M | ﹤0.01% |
20,271
-55,681
| -73% | -$3.59M |
|
1321
Quaker Houghton
KWR
$2.46B
| $1.3M | ﹤0.01% |
6,348
+1,478
| +30% | +$303K |
|
1322
Surmodics
SRDX
$457M
| $1.29M | ﹤0.01% |
43,981
-8,573
| -16% | -$252K |
|
1323
NB Bancorp
NBBK
$737M
| $1.29M | ﹤0.01% |
+94,377
| New | +$1.29M |
|
|
HUYA
1324
Huya Inc
HUYA
$780M
| $1.28M | ﹤0.01% |
282,400
-12,319
| -4% | -$56.1K |
|
1325
Lloyds Banking Group
LYG
$67B
| $1.28M | ﹤0.01% |
+493,464
| New | +$1.28M |
|